Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...
UK-based SCM Pharma is set to officially launch its own formulation development capability after acquiring new facilities as part of a collaborative deal with the University of Sunderland. The ...
Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, will present new safety and ...
OTTAWA, ON / ACCESSWIRE / June 3, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) and Altus Formulation Inc. ("Altus") today announced the launch of TALLC Corporation ...
LONDON--(BUSINESS WIRE)--Global procurement intelligence advisory firm, SpendEdge, has announced the release of their ‘Pharmaceutical Formulation Equipment Procurement Research Report.’ The insights ...
Edison-based Pharmaceutical Formulations (OTC: PHFR) on Tuesday announced measures directed toward a recapitalization that would convert a significant portion of its current debt to equity. In a ...
Pharma Formulations 2020 Conference is a multidisciplinary program with broad participation with members from around the globe focused on learning about formulations and drug delivery and its advances ...
Greenville, NC, October 09, 2010 --(PR.com)-- Joseph E. "Joe" Cobb Jr., senior formulations scientist at Metrics Inc., has earned the highly respected Certified Pharmaceutical Industry Professional TM ...
The National Pharmaceutical Pricing Authority (NPPA) has fixed and notified the retail price of 37 new drugs in its recent meeting, under the provisions of the Drugs Prices Control Order (DPCO), 2013, ...
LONDON--(BUSINESS WIRE)--Global procurement intelligence advisory firm, SpendEdge, has announced the release of their ‘Pharmaceutical Formulations Market Procurement Research Report.’ The insights and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results